Gamida Cell Ltd. (GMDA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 3.3900 |
| Open | 3.4300 |
| Bid | 3.2100 x 1000 |
| Ask | 3.1300 x 1200 |
| Day's range | 2.9600 - 3.4534 |
| 52-week range | 1.4800 - 5.5900 |
| Volume | |
| Avg. volume | 495,420 |
| Market cap | 180.554M |
| Beta (5Y monthly) | 1.71 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
How Many Gamida Cell Ltd. (NASDAQ:GMDA) Shares Do Institutions Own?
The big shareholder groups in Gamida Cell Ltd. ( NASDAQ:GMDA ) have power over the company. Large companies usually...
- Simply Wall St.
Gamida Cell Ltd. (NASDAQ:GMDA): When Will It Breakeven?
With the business potentially at an important milestone, we thought we'd take a closer look at Gamida Cell Ltd.'s...
- Zacks
Pfizer (PFE) 2nd Ulcerative Colitis Study on Etrasimod Succeeds
Pfizer's (PFE) ELEVATE UC 52 is the second phase III study on etrasimod for ulcerative colitis to have met primary and key secondary endpoints.
© 2022 Yahoo. All rights reserved.
